Critical Path Institute Launches One to Millions Initiative to Standardize and Scale Individualized Genetic Therapies for Rare Diseases

Critical Path Institute launches the One to Millions initiative to standardize the development and regulatory approval of individualized genetic therapies.

By: AXL Media

Published: Mar 27, 2026, 10:11 AM EDT

Source: Information for this report was sourced from Critical Path Institute (C-Path).

HEADLINE

Critical Path Institute Launches One to Millions Initiative to Standardize and Scale Individualized Genetic Therapies for Rare Diseases

SUMMARY

The Critical Path Institute has introduced "One to Millions," a global public-private partnership designed to modernize regulatory and reimbursement frameworks for highly individualized medical treatments. By leveraging a centralized, regulatory-grade data platform, the initiative aims to transition from traditional population-based drug models to a scalable "plug-and-play" system for advanced genetic interventions.

CONTENT

Modernizing the Regulatory Framework for Precision Medicine